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PATIENT RECOURSE IN INTERNATIONAL 
HEALTHCARE: 
ARBITRATION AND INSURANCE FOR SELF-
REFERRED PATIENTS 
 
Thomas S. Terranova* 
 
I. INTRODUCTION 
odern patients travel extensively for healthcare, across town, 
across the country, around the world, facilitated by free flowing 
information and the ability to travel anywhere on the globe. They do 
so for any number of reasons, and the treatment models under which 
they receive care are almost infinitely numerous because international 
healthcare is a vast and diverse marketplace. This Article considers 
the options available to patients when treatment in the international 
arena does not go as planned. Economic realities often pose a difficult 
choice to patients: they can either seek care abroad with no 
established recourse for medical malpractice, or they can remain in 
the United States without the resources to obtain needed services; 
stated simply, no care or no recourse.1 For the purposes of this Article, 
first assume patients seek care from a trained medical professional in 
a facility that, at minimum, purports to provide medical services. 
Although hotel room surgeries, in a completely inappropriate setting, 
or surgeries performed by people merely posing as doctors do occur, 
                                                            
* J.D./M.B.A. Candidate, May 2017, Loyola University Chicago School of 
Law. M.A. June 2007 The University of Chicago Committee on International 
Relations. The author would like to gratefully acknowledge Massimo Manzi, the 
Executive Director of PROMED for sharing so many documents and thoughts on 
this subject. 
1 See I. GLENN COHEN, PATIENTS WITH PASSPORTS: MEDICAL TOURISM, LAW, 
AND ETHICS 96-97 (OXFORD UNIV. PRESS ed., 2014). 
M 
Terranova Article.docx (Do Not Delete) 5/1/15  10:35 PM 
424 Loyola Consumer Law Review Vol. 27:3 
these are not considered in this Article. Second, presume that patients, 
particularly Americans, expect an avenue to collect damages in the 
case of malpractice. Tort law demands holding parties responsible for 
injuries they cause, and the principle permeates not only American 
jurisprudence but also daily life and concepts of fairness. Therefore, 
the patients whose recourse this Article considers, traverse borders to 
receive legitimate medical care and expect some opportunity to 
recover damages—a fundamental concept of common law. The 
following pages discuss emerging options to provide patients with the 
expected level of protection by offering avenues for recovery while 
maintaining sufficient competitive advantages and protections to keep 
doctors participating in international healthcare. In order to keep this 
endeavor manageable, this Article only addresses a specific group of 
international healthcare patients; however, the concepts are broadly 
generalizable. 
The rest of this Article discusses the current situation in 
international healthcare and examines attractive early stage options 
for patient recourse. Section II provides basic background information 
about the phenomenon of international healthcare. Section III 
discusses the size and scope of international healthcare and focuses 
the conversation on the market segment being examined here. In 
Section IV, the Article examines the medical malpractice gap for 
international patients and its impact on patients, their native countries, 
the physicians, and the treating countries. Section V explores Costa 
Rica’s alternative dispute resolution scheme as offering a potential 
solution for the remedy gap that is worthy of further experimentation. 
Section VI examines procedure-specific insurance products as a way 
to protect patients and providers from the financial ramifications of 
malpractice. Finally, Section VII of this Article concludes that 
international arbitration and one-time insurance regimes provide the 
bases upon which a framework should be built to offer recourse to 
patients. 
II. THE GLOBAL HEALTHCARE MARKETPLACE: BACKGROUND AND 
CONCERNS 
Medical Travel, Medical Tourism, Health Travel or any of the 
other seemingly infinite iterations of the term describing this concept, 
is a major and growing part of healthcare that simply cannot be 
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ignored, with an estimated market of approximately $50 billion in 
2014.2 However, to discuss the topic as if the patients seeking care 
were a monolithic group with common interests would be a mistake. 
Also, to attempt to examine the entire phenomenon is too large an 
endeavor for this Article. Rather, in the following pages this Article 
focuses on one class of patients and their options for remedy. This 
Article deals with the hard cases by design. Emulating developments 
in international healthcare that protect these patients, in turn, has 
powerful implications for all international patients. There are 
promising remedial concepts for self-referred outpatient care that can 
easily be expanded to protect patients with more substantial 
relationships to the United States’ healthcare system and institutions. 
The industry is at a point of experimentation. It is inconceivable that 
anyone could devise an entire system of appropriate legal remedies as 
a planned concept without unintended consequences. Instead, the 
international healthcare marketplace must mature organically through 
competent, well-informed engagements and networks of bi-lateral 
agreements to find the appropriate mix of protection and added costs 
that give patients from various countries their desired level of 
security. Now is the time to follow promising concepts, observe the 
marketplace’s reactions, and cultivate a comprehensive system of 
protections that fits the needs and expectations of the market actors. 
This Article uses the term international healthcare rather than 
medical tourism. While international healthcare is probably the least 
used term for this sector, it is the most appropriate.3 To highlight the 
travel or tourism elements of international healthcare only trivializes 
care and contributes to patients making decisions with less diligence 
than when making a “serious” healthcare choice. Minimizing the 
healthcare features of the transaction exacerbates the deleterious 
effect of marketing terms like, “minor procedure”, “minimally 
                                                            
2 Reenita Das, Medical Tourism Gets a Facelift…and Perhaps a Pacemaker, 
FORBES (Aug. 19, 2014, 2:48 PM), 
http://www.forbes.com/sites/reenitadas/2014/08/19/medical-tourism-gets-a-facelift-
and-perhaps-a-pacemaker/.  
3 See David Wainer, Come for the Seven-Star Hotel, Stay for a Nose Job, 
BLOOMBERG BUSINESS (Sept. 24, 2014, 3:01 PM), 
http://www.bloomberg.com/news/articles/2014-09-24/come-for-the-seven-star-
hotel-stay-for-a-nose-job (exemplifying the use of luxury or adventure as the 
attraction to bring patients into a country for treatment with less emphasis on care). 
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invasive”, and others that lead patients to believe they face no medical 
risks.  
International healthcare has gained recent notoriety as a 
market segment primarily because the United States has become one 
of the largest exporters of patients in the world.4 Travelling abroad for 
healthcare dates back to antiquity. Ancients travelled to more 
hospitable destinations for mineral treatments and convalescence.5 In 
more recent times, the United States was the world’s primary importer 
of patients due to its advanced technology.6 The wealthy citizens of 
the world frequently travelled to America for the pinnacle of specialty 
care in settings like the Mayo Clinic, Cleveland Clinic, or Johns 
Hopkins. And while the United States continues to attract such 
patients, large areas of healthcare have increasingly become 
commodity services that can be adequately delivered in many parts of 
the world. As a result, Americans are being targeted as consumers for 
healthcare abroad. This Article refers to them as outbound patients. 
It is concerning that outbound Americans are often treated as 
consumers, a market segment to be attracted and captured by foreign 
providers, rather than as patients. By emphasizing travel, leisure, and 
even adventure to the international patient, the healthcare aspect of the 
travel becomes secondary and can deemphasize the normal risks 
associated with treatment or the aftercare components of healthcare 
that can affect outcomes and long-term patient health.7 Patients may 
not always make their decisions based solely on the best medical fit if 
their judgment is clouded by destination and activity decisions, 
especially when their medical treatment has been presented as an 
ancillary consideration. It is critical to focus on the healthcare aspects 
of international healthcare and develop reasonable patient recourse 
regimes because by potentially perverting decision-making, patients 
may choose lower quality care, experience higher rates of adverse 
events, and actually increase the odds of needing some method of 
remediation. 
                                                            
4 Das, supra note 2. 
5 Hao Li & Wndy Cui, Patients Without Borders: The Historical Changes of 
Medical Tourism, 83 Issue 2 Univ. of W. Ont. Med. J. 20, 20 (2014). 
6 Id. 
7 See Medical Tourism, CTR. FOR DISEASE CONTROL & PREVENTION, 
http://www.cdc.gov/features/medicaltourism/ (last Updated February 23, 2015) 
(encouraging outbound patients to verify that any “vacation” excursions or activities 
are permitted post-operatively before planning them). 
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III. EVOLUTION AND COMMODITIZATION OF HEALTHCARE: THE 
UNITED STATES’ PATIENT EXPORT AND SEGMENTATION 
The global healthcare marketplace is a nascent sector and is 
often incompletely represented by the media, scholars, and indeed the 
industry itself. Discussions about international healthcare typically 
focus on big-ticket inpatient care such as cardiac bypass or joint 
replacement.8 This is true of promotional material, quality and safety 
studies, and examinations of the patient’s legal recourse.9 The 
international healthcare conversation is familiar with hospital 
accreditation by the Joint Commission International, but there is little 
discussion about patients in other settings such as ophthalmology, 
oncology, diagnostic, or dental clinics. When employers’ health plans 
incentivize patients to seek care in a foreign country for medically 
necessary procedures, there are numerous actors who are potentially 
liable for damages in American courts. The employer, insurer, and 
any affiliated American healthcare institutions are potential parties for 
a suit through various theories of liability, although it remains to be 
seen if American courts will accept such theories.10  
Nonetheless, a sizeable number of America’s outbound 
international patients seek foreign care and pay out-of-pocket for any 
                                                            
8 See Symposium, Cross-Border Health Care: The Movement of Patients, 
Providers, and Diseases. LOY. U. CHI. INT’L. L. REV. & BEAZLEY INST. FOR 
HEALTH L. & POL’Y (2015) (presenting many aspects of international healthcare 
focused on transplants, health justice, epidemiology, and inpatient care with no 
mention of patients seeking self-funded outpatient care). 
9 See Deloitte Center for Health Solutions, Medical Tourism: Consumers in 
Search of Value, (2008) [hereinafter Deloitte, Consumers in Search of Value] (using 
the word hospital over eighty times while referring to outpatient-only locations three 
times); See also COHEN, supra note 1 at 80-86 (examining medical malpractice 
liability for a hypothetical American patient primarily in the context of receiving 
care at a hospital); See also Edward Kelley, Medical Tourism, Presentation to World 
Health Org. Patient Safety Programme (Oct. 2, 2013) available at 
http://www.who.int/global_health_histories/seminars/kelley_presentation_medical_t
ourism.pdf (discussing inpatient hospital pilot insurance programs). 
10 Nathan Cortez, Recalibrating the Legal Risks of Cross-Border Health Care, 
10 Yale J. Health Pol’y L. & Ethics 1, 8, 14-17 (2010) (acknowledging there are no 
cases or test cases to indicate the potential liability of foreign providers or 
intermediary, employers, or insurers in the United States and detailing the myriad 
challenges facing a patient attempting to hold one of these parties liable in the 
United States). 
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number of reasons.11 Such patients may be seeking elective 
procedures that are not covered by existing insurance.12 Outbound 
Americans may also want procedures that are unavailable in the 
United States due to legal prohibitions or a lack of regulatory 
approvals, or may be looking for less expensive alternatives because 
they are among the massive population of uninsured Americans, many 
of whom will remain uninsured despite the Affordable Care Act.13 
Patients may also go abroad for care because they are immigrants 
from the treating country, want to receive care in their native land, 
and possibly be cared for post-operatively by family or friends. Some 
international patients are also members of the American expatriate 
community who need or want care while living abroad.14  
In addition to selecting care providers without being counseled 
to do so by an employer, insurer, or facilitator, many patients undergo 
care in outpatient settings that are less likely to have affiliations with 
American institutions.15 These patients have fewer potential parties 
against whom to file suit in American courts, even if case law 
develops to support such liability theories in cross border healthcare.16 
                                                            
11 Kelley, supra note 9. (citing OECD report indicating cosmetic surgery, 
elective surgery, & fertility treatment are the most common treatments in 
international healthcare) 
12 See Brandon Green, Dental Tourism Could Save You Big Money, 
FOXNEWS.COM (Nov. 1, 2013) http://www.foxnews.com/travel/2013/11/01/saving-
big-with-dental-tourism/ (noting an industry publication that estimated there would 
be approximately 500,000 outbound American patients for dental treatment alone in 
2013). 
13 See Wendell Potter, Millions of Middle Class Americans Will Remain 
Uninsured Despite Obamacare, THE CTR. FOR PUB. INTEGRITY (Feb. 2, 2015, 5:00 
AM) http://www.publicintegrity.org/2015/02/02/16681/millions-middle-class-
americans-will-remain-uninsured-despite-obamacare (noting the Congressional 
Budget Office estimates 31 million Americans will remain uninured in ten years); 
See also COHEN, supra note 1, at 95. 
14 Most estimates and statistics for international healthcare do not include 
expatriates, however, these patient populations are at least relevant to consider in the 
context of legal recourse. See Medical Tourism Statistics & Facts, PATIENTS 
BEYOND BORDERS, http://www.patientsbeyondborders.com/medical-tourism-
statistics-facts (last updated July 6, 2014).  
15 Tilman Ehrbeck, Ceani Guevara & Paul D. Mango, Mapping the Market for 
Medical Travel, McKinsey Q., May 2008, at 2-3 (recognizing that substantial 
numbers of patients travel for outpatient procedures, the study also excludes 
expatriates receiving care, wellness care, and emergency care). 
16 See COHEN, supra note 1 at 84-85 (noting personal jurisdiction in the United 
States would be easier to establish if the foreign provider actively targeted American 
 
Terranova Article.docx (Do Not Delete)  5/1/15  10:35 PM 
2015 International Healthcare 429 
So the majority of the discussion of globalized healthcare ignores 
remedies for this large and very exposed subset of international 
patients. If the marketplace can devise protection for these patients, it 
will certainly add an extra layer of protection for those patients who 
are more connected to American jurisdictions by virtue of agents who 
guide care toward foreign providers. Therefore, this Article focuses 
solely on American outbound healthcare, in which the patient pays 
out-of-pocket and uses no professional services in choosing a 
provider. This is the segment of the international healthcare market 
that is hardest to protect and may include hundreds of thousands of 
patients.17 
IV. THE INTERNATIONAL HEALTHCARE MARKET’S REMEDY GAP 
This section continues under the assumption that American 
common law and jurisprudence reinforce the American patient’s 
expectation to have recourse in cases of medical malpractice. Further, 
it assumes the legal and regulatory communities agree that medical 
malpractice remedies serve the concept of fairness by issuing 
judgments against physicians who cause patient injuries. The question 
remains, how can a patient receive adequate protection against 
malpractice when the physician is the citizen and domiciliary of a 
foreign country and has no agents within the United States?  
Truthfully, little can be done to fully protect patients who 
travel for healthcare because the industry represents a vast free-market 
model in which patients decide how diligently and with what 
protections they will participate. If adding protective remedies reduces 
cost savings too much, patients may choose to go farther afield into a 
less regulated market for the cheapest care. Essentially, the patients 
assume the level of risk with which they are comfortable. However, 
an ancillary result of medical complications is the burden on the 
patient’s native health system, in this case the American healthcare 
system, to perform revisions and follow-up care. Therefore, 
                                                            
patients or employed an intermediary to avail themselves of a state’s laws in order 
to secure patients for the provider). 
17 The author bases this statement on Patients Beyond Borders’ 2012 estimate 
of 400,000 outbound American dental patients. If only twenty-five percent travelled 
abroad without the help of an agent, the segment would include over 100,000 
patients without even considering those seeking care from other medical specialties. 
See Green, supra note 12. 
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government agencies have a sizeable incentive to ensure adequate 
patient recourse in the international healthcare arena. Finally, the lack 
of clarity regarding remedies also distorts physician participation in 
international healthcare.  
A. Impact on the Patient Population 
The uncertainty surrounding remedies has very obvious 
implications for patients and their decision-making. American patients 
receiving care abroad are severely limited in their ability to recover 
for medical malpractice in comparison to patients treated domestically 
because of issues with personal jurisdiction, forum non conveniens, 
choice of laws, enforcing judgments, and suing abroad (in the treating 
country).18 Since the individual patient cannot recover for 
malpractice, the entire patient population is somewhat exposed 
because there is no medical malpractice deterrent to dissuade 
physicians from future negligent care.19 However, given the extremely 
high cost of healthcare in the United States, the choice for many 
patients who will pay out-of-pocket is to either accept limited or no 
medical malpractice recovery, or to forego treatment altogether.20 
Absent a remedy, any complications from international healthcare 
require the patient to pay out-of-pocket for major follow up care. Self-
pay is not an ideal situation for patients that have already made 
healthcare choices based on cost. It is also possible for the patient to 
secure private arrangements with the original treating physician to 
correct medical errors, which is also far from ideal since the patient 
may not be enthusiastic about being treated by the same physician a 
second time.  
The out-of-pocket patient population is a diverse group with 
tremendous variation in income and sophistication.21 Therefore, 
patients may calculate their selection of providers differently based on 
balancing the total cost savings, the location’s or provider’s overall 
quality and safety, and over time, the opportunity to recover for any 
medical malpractice. Some patients will certainly sacrifice a degree of 
                                                            
18 These challenges are beyond the scope of this Article and are expertly 
discussed in other works. see COHEN, supra note 1 at 83-89. 
19 But see id. at 81-82 (acknowledging the deterrent effect of malpractice 
judgments is debatable). 
20 See id. at 96-97. 
21 See id. 
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safety and quality standardization, or the prospect of malpractice 
recovery, in exchange for needed financial relief at the outset. It is 
imperative to develop the means to offer patients recourse while 
maintaining a sufficient enough financial incentive to keep them from 
either foregoing care entirely or opting for treatment in a completely 
unregulated and undeveloped medical market with a high probability 
for complications. Ultimately, a system with patient remedies that 
maintains significant cost savings should result in the channeling 
regime favored by Professor I. Glenn Cohen.22 Whether channeling is 
an organic product of the industry or a formal recognition process 
devised through an agency such as the State Department or 
Department of Health and Human Services is unimportant, so long as 
the patient understands the treatment and remedy options available 
and no longer faces the choice of no care or no recourse. 
B. Exposing the Home Country 
The patient’s choice to seek care abroad has important 
implications for the health system of the patient’s home country. 
Should complications arise after international healthcare, particularly 
acute adverse events requiring immediate medical attention, the 
American public health system will likely have to assume the 
responsibility of treating the patient. As discussed above, the self-
funded market segment at issue in this Article is likely uninsured or 
underinsured,23 leaving a sizeable portion of the financial burden on 
public institutions. 
Although this Article specifically addresses outbound 
American patients, the British National Health System (NHS) 
provides useful analogous data that might suggest the total cost 
incurred by American taxpayers to treat complications for 
international healthcare.24 In 2010 the NHS estimated 1,890 
                                                            
22 See id. at 108-15 (acknowledging that a ban on international healthcare is 
unlikely and would be ineffective, and discussing disclosing medical malpractice 
remedies or requiring remedies as conditions for official American agency approval 
to incentivize countries to adopt medical malpractice regimes and influence patient 
decision making). 
23 See id. at 96-97. 
24 See Neil Lunt, et al., Implications for the NHS of inward and outward 
medical tourism: a policy and economic analysis using literature review and mixed-
methods approaches, 2 Issue 2 HEALTH SERV. & DELIVERY RES. at 83, 87, 111-112 
(2014). 
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international patients would need follow up care at a cost of 
approximately £8.2 million.25 This figure is based only on the 
estimated 18,900 outbound British patients who sought cosmetic care 
abroad.26 Meanwhile, the entire British outbound international patient 
population in 2010 was only about 63,000.27 Compare the British 
figure with the approximately 875,000 Americans who travelled 
abroad for care that same year.28 Assuming public programs also treat 
the majority of American complications and that complications occur 
at a comparable rate as they do for British patients, the estimated cost 
of complications on the United States’ health system is staggering.  
To date, there is insufficient data to calculate whether the costs 
of treating those complications outweigh the overall savings that 
outbound tourism bestows on the health system. However, whether 
international healthcare is a net profit or loss for the American health 
system is irrelevant. Tort law demands judgments in favor of a 
plaintiff be imposed on the party responsible for causing an injury, not 
incurred by an innocent third party. Therefore, should international 
healthcare procedures result in complications from malpractice, there 
must be a system of redress that absolves the patient’s home country 
from shouldering the cost of the foreign physician’s tortious act. To 
impose the cost of errors on the federal or state governments 
(effectively the taxpayers), violates the concept of fairness and 
stretches the rational limits of proximate causation. Instead, the 
physician must be held responsible for any negligence or malpractice 
directly, but in a manner that does not scare them out of international 
healthcare entirely. 
 
 
                                                            
25 Id. at 111. 
26 See id. (calculating the number of patients travelling for cosmetic treatment 
based on IPS data and several surveys). 
27 Johanna Hanefeld, et al., Abstract, Medical Tourism: a Cost or Benefit to the 
NHS, PLOSONE (Oct. 24, 2013) 
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0070406#reference
s. 
28 Duncan McGowan, The Rise of Medical Tourism in Panama, VACATION 
NEWS (Oct. 17, 2013, 11:04 AM) http://www.worldpropertyjournal.com/featured-
columnists/the-panama-wire/medical-tourism-panama-healthcare-costs-medical-
procedures-medical-tourists-cosmetic-surgery-fertility-treatments-dental-implants-
hospital-punta-pacifica-7514.php.  
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C. The Physician’s Catch 22 
In the absence of a malpractice regime, American patients face 
the choice of no care or no remedy. Treating physicians, on the other 
hand, must decide whether to cede jurisdiction to the American court 
system, offer no additional protection and potentially scare off 
patients, or devise a private offering to ease any lingering patient 
fears. Of all the areas of international healthcare presenting a dearth of 
information, the physicians’ decision making is the least documented. 
Physicians who work in international healthcare are a sophisticated 
group of actors, many of whom are familiar enough with American 
medical malpractice judgments to know that they do not want to be 
subject to American judgments. If physicians did choose to submit to 
American jurisdiction, adequately protecting themselves from 
devastating judgments would raise expenses through additional legal, 
insurance, and administrative fees. It would diminish the cost savings 
they offer to Americans and damage their value propositions. For the 
same reasons a patient may want to subject a doctor to American 
jurisdiction, no logical doctor would contract to become subject to 
American courts.  
However, physicians do understand that American patients 
expect some protection. Failing to provide any remedial option 
diminishes the physician’s offering and potentially keeps patients out. 
As a compromise, many physicians offer to conduct follow-ups or 
corrections at no cost, or pay for the cost of additional services 
necessitated by a bad outcome. Once a patient has a complication, 
however, it is safe to assume that the relationship has become 
somewhat damaged and the patient may not be willing to trust the 
operating physician to treat them again, or even to pay for adequate 
treatment. The system needs something more structured. Physicians 
and their home countries have an incentive to provide reasonable 
recourse without submitting to American jurisdiction and being 
exposed to the risk of the rare mega judgments it produces. They must 
provide some protection, or risk losing any competitive edge they 
might have over American healthcare. In the case of the treating 
country, spoiling inbound international healthcare jeopardizes 
potentially billions of dollars in revenue. 
D. National Embarrassment to the Treating Country 
International healthcare is a matter of national importance for 
several countries at the forefront of the industry. Some governments 
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have identified international healthcare as a major national strategic 
imperative and now compete with the rest of the globe to advance 
their own particular market offering.29 The billions of dollars at stake 
annually justify a major national investment. A prime example is 
South Korea, which founded the Korea Health Industry Development 
Institute (KHIDI), a public-private institution, in 1998.30 The institute 
has a twofold purpose to improve the national health industry and 
strengthen the international competitiveness of the Korean health 
industry.31 KHIDI has an annual budget of $400 million, employs 
approximately 400 people, and maintains six offices outside of 
Korea.32 Similarly, Costa Rica identified quality healthcare and 
English language penetration among its own competitive advantages 
and created the Council for the International Promotion of Costa Rica 
Medicine (PROMED) to advance the country’s interests in the 
international marketplace.33 In 2015, PROMED will host its fifth 
annual summit series on international healthcare, the second year in 
which events are set to take place inside the United States.34 
The above are just two examples of the increasingly common 
strategic national investments countries have made to attract 
international patients. There are similar organizations throughout the 
world but it is unnecessary to detail them all, rather, it is sufficient to 
note that multiple nations devote millions of dollars toward 
                                                            
29 See Deloitte, Consumers in Search of Value, supra note 9, at 6 (identifying 
10  hubs for international healthcare Brazil, Costa Rica, Gulf States, Hungary, India, 
Malaysia, Mexico, Singapore, South Africa & Thailand & substantial efforts in the 
Philippines & South Korea). 
30 History, KOREA HEALTH INDUS. DEV. INST., 
http://www.khidi.or.kr/board?menuId=MENU00773 (last visited Feb. 23, 2015). 
31 Purpose of the Institute, KOREA HEALTH INDUS. DEV. INST., 
http://www.khidi.or.kr/board?menuId=MENU00772 (last visited Feb. 23, 2015).  
32 About, KOREA HEALTH INDUS. DEV. INST., 
http://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=4&cad=rja&
uact=8&sqi=2&ved=0CDcQFjAD&url=http%3A%2F%2Fwww.khidi.or.kr%2Ffile
Download%3FtitleId%3D106281%26fileId%3D2&ei=2rTrVKgrieewBNbpgoAG&
usg=AFQjCNG9ayUzU1AQA5N5Ne5nHt-N0p8riA&bvm=bv.86475890,d.cWc 
(downloaded Feb. 23, 2015). 
33 About PROMED, COUNCIL FOR THE INT’L PROMOTION OF COSTA RICA MED., 
http://www.promedcostarica.org/about/ (last visited Feb. 23, 2015) [hereinafter 
About PROMED].  
34 Home, MED. TRAVEL INT’L. BUS. SUMMIT, 
http://themedicaltravelsummit.com/ (last visited Mar. 31, 2015). 
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developing and promoting their international healthcare programs.35 
Treating countries have the same incentives as individual treating 
physicians to offer satisfactory avenues to malpractice recovery. The 
main difference is that the national strategic interest magnifies the 
individual concerns of the physician because it aggregates the 
earnings from all inbound patients. National economic interests also 
include those from ancillary services related to care and recovery as 
well as hotels, meals, and non-health related services and 
excursions.36 The stakes are high; patients may be scared off in droves 
to pursue care in a competing nation because of high-profile 
complications in which the patient was unable to recover. Treating 
countries may lose out on tens of millions of dollars of income. 
Recently a British patient died after undergoing surgery in Thailand, 
the media coverage highlighted the potential financial ramifications of 
bad outcomes on treating countries.37  
It is in the best interest of treating countries to help formalize 
an international regime for patient recovery because leaving patients 
financially exposed to adverse outcomes threatens the long-term 
viability of a national economic sector potentially worth millions. 
Each adverse outcome in which the patient does not receive 
satisfactory compensation increases the chances of negative public 
                                                            
35 There is no consolidated list of official or semi-official national promotion 
organizations. See e.g. Medical Clusters in Mexico, MEX. TOURISM BD., 
https://www.visitmexico.com/en/health/hospitals/medical-clusters-in-mexico (last 
visited Mar. 30, 2015); see also e.g. Thailand Medical Tourism Portal, TOURISM 
AUTH. OF THAI., http://www.thailandmedtourism.com/Home/28 (last visited Mar. 
30, 2015); see also e.g. Medical Travel, SING. TOURISM BD., 
https://www.stb.gov.sg/industries/healthcare (last visited Mar. 30, 2015); see also 
e.g. 2014 Sponsors: World Medical Tourism & Global Healthcare Congress, MED. 
TOURISM ASS’N., http://www.medicaltourismcongress.com/2014-sponsors/ (last 
visited Mar. 30, 2015). 
36 JOHN CONNELL, MEDICAL TOURISM 132-133 (Sarah Hulbert & Shankari 
Wilford eds., 2011) (noting medical tourists spend two to three times more than 
standard tourists with a significant amount of spending outside of healthcare and 
creating many non-healthcare jobs). 
37 Francesca Infante, British Woman Who Died in Thailand During Buttock 
Surgery as Brother Reveals Family 'Still Don't Know What Went Wrong', THE 
DAILY MAIL (Oct 29, 2014, 7:24 PM), http://www.dailymail.co.uk/news/article-
2813420/Pictured-British-woman-died-Thailand-buttock-surgery-brother-reveals-
family-don-t-know-went-wrong.html (explaining the patient died as a result of 
corrective surgery when her implants became infected, also noting Thailand made 
£2.68 billion from inbound international healthcare in 2013). 
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perception and heightened discourse over the ability of treating 
physicians and advisability of receiving care in the treating country. 
Creating a robust scheme for patient recourse makes it clear that the 
treating physician and treating country are responsible, have given 
adverse outcomes sufficient forethought, and have instituted a 
reasonable method of resolving disputes.  
 
V. EXPERIMENTING WITH ARBITRATION SCHEMES OFFERS THE 
PROSPECT OF ADEQUATE REMEDY 
Ultimately, whatever available safeguards can be implemented 
to protect patients and the national healthcare system should surely be 
implemented. In fact, reasonable malpractice remedies are in the best 
interest of all stakeholders and are beginning to crystallize in 
international healthcare. International healthcare transactions are, by 
nature, bi-lateral arrangements. The patient’s home country, the 
United States for this Article, represents one side of the transaction 
and the treating country represents the other. The United States 
generally has some sort of broader trade relationship with the treating 
country, as long as the patient does not undergo treatment in an 
embargoed nation such as Iran or North Korea. It therefore makes 
sense to look to those existing relationships for ideas to model a 
liability and dispute resolution system that will function globally. 
 Bi-lateral alternative dispute resolution schemes are those in 
which the patient’s home country and the treating country recognize 
the validity of arbitration and conciliation awards in each other’s 
territory and have established at least one organization that is 
sufficiently impartial to conduct an unbiased process.38 Such 
programs provide legitimate patient recourse that bridges the gap 
between an acceptable legal remedy and a wild-west medical 
environment offering no legal recourse, thus avoiding all 
administrative and transaction costs associated with a malpractice 
                                                            
38 The Costa Rican-American Chamber of Commerce houses the Arbitration 
and Conciliation International Center and enjoys nearly equal membership from the 
United States and Costa Rica. The Chamber accounts for the majority of Costa 
Rica’s foreign direct investment and exports. This organization has an incentive to 
provide an unbiased process for claims between Americans and Costa Rican’s 
because it represents the interests of both parties. See About Us, THE COSTA RICAN-
AM. CHAMBER OF COM., http://www.amcham.co.cr/about_amcham.php (last visited 
Feb. 12, 2015) [hereinafter About Us, Am-Cham].  
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process. As discussed above, physicians treating American patients 
are well aware of the ramifications of medical malpractice suits and 
the reputation of the United States court system for granting large 
judgments. These sophisticated actors often make a conscious 
decision to limit their exposure while offering patients some measure 
of protection. One thing patients and lawyers can be sure of is that 
these doctors will not willingly cede jurisdiction to the United States. 
However, most physicians are aware that failing to provide any 
recourse will eventually scare off a large number of patients. 
Costa Rica is a leading provider of healthcare to outbound 
American patients and offers a regime that may provide a path 
forward. Costa Rica has based its development on its human 
intellectual capital, with a well-educated but fairly inexpensive 
workforce.39 The country considers medical travel a strategic national 
imperative and has committed to quality throughout the healthcare 
system.40 The country established the Council for the International 
Promotion of Costa Rica Medicine (PROMED) as a non-profit 
organization to position Costa Rica as a leader in international 
healthcare.41 PROMED first attempts to limit adverse outcomes by 
requiring all members providing healthcare or ancillary services to 
meet all national licensing standards as well as to achieve 
international accreditation generally recognized in the United States, 
Canada, or Europe.42 
It is admirable that Costa Rica attempts to avoid catastrophes 
by only allowing the highest quality providers to participate in its 
national promotion scheme. For the purposes of medical malpractice 
remedies, however, the country’s solution to post-treatment patient 
dispute resolution is more valuable for study and imitation. In addition 
to offering international quality, Costa Rica offers internationally 
                                                            
39 Andrès Rodrìguez-Clare, Costa Rica’s Development Strategy Based on 
Human Capital and Technology: How It Got There, the Impact of Intel, and Lessons 
For Other Countries. UN DEV. PROGRAMME 1, 16-17 (2001). available at 
http://eml.berkeley.edu/~arodeml/Papers/CRDevelopmentStrategy.pdf.  
40 Decretos N°35054-S-COMEX-COM-TUR. 34 LA GECETA 2 (Feb. 18, 2009) 
available at http://www.gaceta.go.cr/pub/2009/02/18/COMP_18_02_2009.html. 
41 About PROMED, supra note 33. 
42 PROMED: Requirements For Membership, COUNCIL FOR THE INT’L 
PROMOTION OF COSTA RICA MED., http://www.promedcostarica.org/join-
promed/membership/requirements (last visited Feb. 23, 2015). 
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acceptable options for legal recourse.43 To that end, PROMED advises 
its members to use alternative dispute resolution by including an 
arbitration clause in their contracts with patients.44 PROMED 
endorses the Arbitration and Conciliation International Center (CICA) 
housed at the Costa Rican–American Chamber of Commerce 
(AmCham) to settle disputes.45  
AmCham is more than forty years old.46 The organization’s 
membership is approximately 400 companies and 1,300 corporate 
representatives with about equal distribution between Costa Rican and 
American members.47 Additionally, AmCham is responsible for about 
eighty percent of Costa Rica’s foreign direct investment and 
approximately the same percentage of Costa Rican exports.48 CICA 
was founded in 1999 and is a non-profit entity dedicated to providing 
conciliation and arbitration services to resolve commercial disputes.49 
CICA promotes the fact that its conciliation and arbitration processes 
resolve ninety-five percent of controversies presented.50 Further, 
CICA’s arbitration process has a maximum time limit of seven 
months.51 Alternative dispute resolution is an attractive option 
compared to the unpredictable and lengthy processes offered by the 
Costa Rican court system.52 Even if it takes twice as long to settle a 
                                                            
43 CICA: International Center for Conciliation & Arbitration, COUNCIL FOR 
THE INT’L PROMOTION OF COSTA RICA MED., http://www.promedcostarica.org/join-
promed/membership/benefits/conflict-resolution/ (last visited Feb. 11, 2015) 
[hereinafter PROMED, CICA].  
44 Costa Rica Safe Destination for Medical Travelers, COUNCIL FOR THE INT’L 
PROMOTION OF COSTA RICA MED., (unpublished promotional material) (on file with 
PROMED) [hereinafter Costa Rica Safe Destination]. 
45 Id. 
46 About Us, Am-Cham, supra note 38. 
47 Id. 
48 Id. 
49 About Us, ARBITRATION AND CONCILIATION INT’L. CTR., 
http://www.cica.co.cr/pages/cica (last visited Feb. 12, 2015) [hereinafter CICA, 
About Us]. 
50 Id. 
51 Id. 
52 PROMED, CICA, supra note 43 (“PROMED supports the alternative dispute 
resolution (ADR) process because resolution of a dispute, depending on the 
complexity of the case, could take years in the Costa Rican courts and with no 
guarantee of a satisfactory result for either party”). 
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case as CICA’s maximum limit allows, malpractice claims would be 
resolved long before the average case in American courts.53 
PROMED, Costa Rica’s government ministries, and the 
medical community recognize that the country’s medical 
infrastructure, educational capacity, human intellectual capital, natural 
beauty, and English proficiency make an attractive offering.54 
However, they also realize that the offering is incomplete if the 
country and its healthcare providers fail to make patients feel secure 
by offering a remedy for malpractice.55 All industry actors are 
concerned with the prospect of being held liable for malpractice 
against an American patient because of America’s reputation for 
litigation and large financial awards.56 So, no competent foreign 
physician will willingly submit to American jurisdiction. PROMED, 
therefore advises healthcare providers to offer conflict resolution as 
one of four necessary components of making Costa Rica a safe 
healthcare destination and establish the country as a leader in 
international healthcare.57 Conflict resolution through CICA is so 
central to Costa Rica’s value proposition that the organization 
provides members with boilerplate conciliation and arbitration clause 
language.58 
Despite the common criticisms of arbitration in general, the 
regime offered by CICA is equivalent to arbitration regimes to which 
American patients may freely contract when receiving domestic care. 
In fact, CICA boasts a cooperative agreement with the International 
Section of the American Arbitration Association (AAA).59 CICA’s 
published rates60 are comparable to those published by AAA for either 
                                                            
53 Jena Anumpam, et al., Outcomes of Medical Malpractice Litigation Against 
US Physicians, 172 No. 11 JAMA Internal Medicine (2012), available at 
http://archinte.jamanetwork.com/article.aspx?articleid=1151587 (finding the mean 
length of a litigated malpractice case in the United States to be 25.1 months). 
54 Stephen Wiener Esq., An Introduction to Legal Issues In Medical Travel: 
What to Worry About, or Not, Presentation at The Medical Travel International 
Business Summit. San Jose, Costa Rica (May 2-4, 2011). 
55 Id. 
56 Id. 
57 Costa Rica Safe Destination, supra note 44. 
58 Id. 
59 CICA, About Us, supra note 49. 
60 Tarifas, ARBITRATION AND CONCILIATION INT’L. CTR., 
http://www.cica.co.cr/pages/tarifas (last visited Feb. 12, 2015) [hereinafter CICA, 
Tarifas]. 
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general arbitration61or the International Centre for Dispute 
Resolution.62 Similarly, all of these organizations offer arbitration by 
single neutral parties or tribunals.63 
Based on the equal distribution of interests and financial 
commitments between the United States and Costa Rica in 
AmCham’s membership, American patients are not likely to suffer at 
the hands of a bias and hostile system. CICA has significant 
incentives to provide fair and equitable resolutions. In addition, the 
American judicial system is not overly friendly to malpractice 
plaintiffs. The court dismisses more than half of all claims, and 
approximately eighty percent of the small number of cases resulting in 
verdicts find in favor of the physician.64 American patients are free 
when undergoing care in the United States to either contract for 
alternative dispute resolution or, absent an agreement, to bring a claim 
in America’s less than hospitable court system. It is no great gamble 
to rely on arbitration in CICA. The only difference is that a clause 
requiring conciliation and arbitration under CICA would likely 
remove the slight but important chance for the mega awards that have 
given America its reputation in the international community. Some 
American courts have even recognized the practical benefits of 
arbitration over the judiciary.65 
As two of the nations that have ratified the New York 
Convention,66 the United States and Costa Rica agree to the 
                                                            
61 Costs of Arbitration (including AAA Administrative Fees), AM. ARBITRATION 
ASS’N., https://www.adr.org/aaa/ShowPDF?doc=ADRSTAGE2026862 (last visited 
Feb. 12, 2015) [hereinafter Costs of Arbitration].  
62 International Dispute Resolution Procedures (Including Mediation and 
Arbitration Rules), AM. ARBITRATION ASS’N., 
https://www.adr.org/aaa/ShowPDF?doc=ADRSTG_004338 (last visited Feb. 13, 
2015) [hereinafter International Dispute Resolution]. 
63 CICA, Tarifas, supra note 60; Costs of Arbitration, supra note 61; 
International Dispute Resolution, supra note 62. 
64 Amy Norton, Docs Win Most Malpractice Suits, but Road is Long, REUTERS 
(May 23, 2012), available at http://www.reuters.com/article/2012/05/23/us-docs-
win-most-idUSBRE84M11N20120523. 
65 See COHEN, supra note 1, at 104 (discussing Madden v. Kaiser Found. 
Hosps., 552 P2d 1178, 1185-86 (Cal. 1976), that arbitration offers a venue for minor 
malpractice claims that cannot economically be resolved in the courts). 
66 New York Convention Countries, N.Y. ARBITRATION CONVENTION, 
http://www.newyorkconvention.org/contracting-states/list-of-contracting-states (last 
visited Feb. 20, 2015). 
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fundamental characteristics of arbitration and recognize the validity of 
the arbitration process employed in each other’s jurisdiction.67 This 
provides a solid, legitimate foundation capable of supporting an 
adequate alternative dispute resolution regime. Widespread accession 
to the New York Convention by so many countries68 indicates that 
despite general questions about the validity of arbitration, there is 
broad international agreement about the process. Thus, this allows 
many nations to provide a sufficient alternative dispute resolution 
regime to adequately protect American patients.  
The industry must build upon the foundation of bi-lateral 
arbitration recognition with alternative dispute resolution institutions 
that are somewhat equally supported by the United States and the 
treating country. One of CICA’s most attractive features is that it 
represents both American and Costa Rican business interests.69 
Despite the fact that CICA has yet to adjudicate an international 
medical malpractice claim, the organization’s equity of interests 
imbues it with credibility and suggests a degree of impartiality that is 
critical to international healthcare. The international healthcare market 
must experiment with these regimes and encourage copycat 
institutions to evolve organically by learning from awards and patient 
behavior to strike the right cord. Ratification of the New York 
Convention and an alternative dispute resolution scheme housed in a 
bi-laterally funded organization are essential to the early iterations 
because such regimes will give patients enough of a sense of home to 
feel adequately protected.  
The Costa Rican model offers quality, safety, and alternative 
dispute resolution. It presents a mix of risk mitigating safeguards and 
remedial protections that reduce the likelihood of complications and 
increase the chances of satisfactory dispute outcomes. The system is 
worthy of imitation and expansion. Based on America’s pervasive 
trade relationships with almost every country where a patient may 
seek care, similar safety and recourse layering may already exist in 
                                                            
67 Convention on the Recognition and Enforcement of Foreign Arbitral Awards 
art. III, United Nations Conference on International Commercial Arbitration (1958). 
68 See Bhutan and Guyana Accede to the Convention on the Recognition and 
Enforcement of Foreign Arbitral Awards, UN INFO. SERV. (Sept. 26 2014), 
http://www.unis.unvienna.org/unis/en/pressrels/2014/unisl207.html (indicating The 
Convention it went into force on December 24, 2014 in both countries bringing the 
number of state parties to 152). 
69 CICA, About Us, supra note 49. 
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other international healthcare providing nations, or if not, the 
infrastructure may be readily available to create them. The American 
Chamber of Commerce has chapters similar to Costa Rica’s AmCham 
in more than ninety foreign countries.70 Each Chamber could support 
an organization like CICA, if it does not already, particularly where 
the host nation has contracted to the New York Convention. This type 
of arbitration relationship requires not only the national relationships 
to foster a fair alternative dispute resolution forum, but the 
commitment and sophistication of the physician population to offer 
such a contract provision and well-informed patients to demand such 
clauses.  
Interested parties such as outbound patients, patients’ rights 
groups, treating physicians, attorneys, and United States government 
agencies are the stakeholders most appropriate to drive the 
development of alternative dispute resolution regimes in other 
countries. The stakeholders should encourage the various Chambers 
of Commerce to create arbitration bodies that equally represent the 
interests of both the American patient and the treating physician. The 
nations involved must recognize each other’s processes to legitimatize 
the scheme and then build an institution with equal representation 
from each country, based on existing trade relationships if necessary. 
Self-referred outbound American patients will then be covered by a 
network of bi-lateral arrangements that provide remedial protections 
consistent with the patient’s expectation for fair compensation in 
cases of medical malpractice. Most important, alternative dispute 
resolution must develop a fair and equitable process patients can trust 
without scaring off physicians based outside the United States. Once a 
global network of alternative dispute resolution venues develops, it 
will become incumbent upon attorneys to ensure their clients do not 
merely jump at the least expensive offer or the flashiest website and 
leave themselves exposed.  
VI. ELECTIVE PROCEDURE INSURANCE PROVIDES ADDITIONAL MEANS 
OF RECOVERY FOR THE INTERNATIONAL PATIENT 
One-time procedure insurance offers an additional layer of 
protection by vetting participating physicians and providing a 
                                                            
70 American Chambers of Commerce Abroad (AmCham) Results for Region, 
CONN. BUS. & INDUS. ASS’N., http://www5.cbia.com/business/american-chambers-
of-commerce-abroad-amcham-results-for-region/ (last visited Feb. 25, 2015). 
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financial safety net accessible by patients with complications resulting 
from international healthcare. Procedure-specific insurance programs, 
especially when paired with alternative dispute resolution schemes 
such as the one discussed above, provide sufficient protections for 
patients as well as the health system of the patient’s home country. 
The International Society of Aesthetic Plastic Surgeons 
(ISAPS) has partnered with an insurer to provide international 
coverage for complication and revision treatments for outbound 
British patients. The program is called ISAPS Insurance and is 
provided by Sure Insurance Services Limited.71 The insurance plans 
attempt to keep the rate of complications consistent with high-quality 
care provided around the globe. This and similar regimes protect 
patient interests and allay physicians’ concerns over major financial 
damages enough to keep them involved in the international healthcare 
marketplace.  
This procedure-specific insurance offers an additional layer of 
protection by vetting participating physicians as well as providing a 
financial safety net. The ISAPS Insurance program is available 
exclusively to ISAPS member surgeons.72 ISAPS membership, and by 
extension the insurance policy, requires participating surgeons to be 
board certified or the local equivalent in countries without official 
board certification.73 By requiring board certification or its equivalent, 
the society and insurance program seek to assure the highest levels of 
clinical competency and specialty training.74 The mitigating effect of 
such a requirement theoretically drives down the need for patient 
claims. 
In the event of a complication, however, The ISAPS Insurance 
program offers protection to the patient, the patient’s home country, 
and the physician through various instruments. Such programs, 
                                                            
71 Who We Are, ISAPS INS., http://isapsinsurance.com/ (last visited Jan. 20, 
2015). 
72 The Policy, ISAPS INS., http://isapsinsurance.com/the-policy (last visited Jan. 
20, 2015).  
73 International Society of Aesthetic Plastic Surgery By-Laws, INT’L SOC’Y OF 
AESTHETIC PLASTIC SURGERY, 
http://www.isaps.org/Media/Default/downloads/ISAPS-By-Laws.pdf (last visited 
Jan. 20, 2015). 
74 See Susumu Takayanagi, MD., A Letter from the President of ISAPS, INT’L 
SOC’Y OF AESTHETIC PLASTIC SURGERY, http://www.isaps.org/about-isaps/letter-
from-president (last visited Jan. 20, 2015). 
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especially when paired with an alternative dispute resolution scheme, 
provide sufficient protections for all parties. 
A. Covering the Patient 
The ISAPS Insurance program covers patients and 
companions through three different instruments sold under the 
product name Medical Travel Shield (MTS).75 The plans are divided 
into three products that cover international dental treatment, cosmetic 
surgery, and elective surgery or in vitro fertilization treatment. 76 All 
three products cover various travel related incidents as well as certain 
medical circumstances for patients between eighteen and sixty-six 
years old.77 The plans provide for corrective treatments, but do not 
cover medical or legal costs related to the planned treatment.78 This is 
why it is so important to pair this type of instrument with an 
appropriate method of recovery (e.g., arbitration), in order to fully 
protect the patient. Any disputes arising out of the policy are governed 
by the patient’s home country, in this case, England and Wales, and 
bring these claims firmly back into familiar jurisdiction.79 
The policy ensures the patient receives necessary care up to £2 
million in the event of a serious incident, including a life threatening 
complication during the planned procedure and the cost of 
repatriation.80 Covered patients also receive a £50 daily hospital 
                                                            
75 The Product, MED. TRAVEL SHIELD, http://medicaltravelshield.com/ (last 
visited Feb. 22, 2015).  
76 Id. 
77 Medical Travel Shield Key Facts Document: For Persons Travelling Abroad 
to Receive Dental Treatment, MED. TRAVEL SHIELD, 
http://medicaltravelshield.com/insurance-documentation (last visited Feb. 24, 2015); 
Medical Travel Shield Key Facts Document: For Persons Travelling Abroad to 
Receive Elective Surgery, MED. TRAVEL SHIELD, 
http://medicaltravelshield.com/insurance-documentation (last visited Feb. 24, 2015); 
Medical Travel Shield Key Facts Document: For Persons Travelling Abroad to 
Receive Cosmetic Surgery, MED. TRAVEL SHIELD, 
http://medicaltravelshield.com/insurance-documentation (last visited Feb. 24, 2015) 
[hereinafter cited collectively as MTS Key Facts] The forms are substantially similar 
in content and format, except each corresponds to coverage for a different type of 
care. The collective citation indicates the breadth of services covered. Subsequent 
pin cites reference the location of content on each of the three forms. 
78 See, MTS Key Facts, supra note 77, at 2. 
79 See MTS Key Facts, supra note 77, at 3. 
80 See MTS Key Facts, supra note 77, at 4, 5. 
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benefit up to a maximum of £1,500, up to £500 for additional foreign 
healthcare consultations before returning home, and up to £2,000 to 
return to the original treating hospital within twelve months for any 
required corrective treatment.81 It is quite difficult to obtain exact 
prices because of the pricing structure for insurance. However, the 
insurance program offers exemplars that suggest patients can protect 
themselves for a modest investment, especially considering the cost 
savings usually associated with foreign treatment.82 One such example 
is a policy covering a seven-day trip from the United Kingdom to 
Poland for elective surgery that costs £191.50.83 
Patients must keep in mind they are receiving medical care, 
not a “minor procedure” that is treated with little more concern than a 
haircut. Purchasing coverage will slightly reduce their substantial 
savings but will cost less than many insured patients pay for one 
month’s premium, therefore it should not be too unpalatable.84 The 
ISAPS Insurance discussed here is currently limited to patients from 
Britain, but it should be replicated and tried in the United States. The 
model employed by the policies,85 which only covers supremely 
trained physicians, should reduce the instances of payouts and exert 
downward pressure on premiums. Hopefully this will keep the 
instruments affordable and offer the right value of contingency 
planning for patients. The policy’s underwriters at Lloyd’s86 are 
surely capable of replicating a quality-driven regime in the United 
States that will not price out patients and drive them to lower cost, 
lower quality treatment locations.  
Insurance coverage such as MTS protects the patient from 
exorbitant out of pocket expenses for emergent or revision treatment 
as a result of the original care.87 Since many of the outbound 
international patients addressed by this Article are financially 
vulnerable when it comes to healthcare expenses, the cost of follow-
                                                            
81 See MTS Key Facts, supra note 77, at 5. 
82 See PATIENTS BEYOND BORDERS, supra note 14 (estimating the range of cost 
savings for American patients in popular treating nations). 
83 How Much Does it Cost?, MED. TRAVEL SHIELD, 
http://medicaltravelshield.com/how-much-does-it-cost (last visited Feb. 8, 2015). 
84 See PATIENTS BEYOND BORDERS, supra note 14 (estimating the range of cost 
savings for American patients in popular treating nations). 
85 See ISAPS INS., The Policy, supra note 72. 
86 See MTS Key Facts, supra note 77, at 8. 
87 See MTS Key Facts, supra note 77. 
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up care is likely to fall on the public health system, specifically 
Medicare, Medicaid, or the hospital whose emergency room admits 
the patient.88 Therefore, procedure-specific insurance also protects the 
patient’s home country from bearing the cost of malpractice and it 
does so in a far more economical way than purchasing traditional 
health coverage. Outbound American patients need such an option, 
and since it would benefit the public healthcare system, institutions 
like the Centers for Disease Control and Prevention and the 
Department of State should produce public service content on the 
subject.   
Each American Embassy and Consulate typically has a United 
States Citizen Service section that lists available services in the 
diplomatic mission’s district, including healthcare.89 This site would 
be the ideal place to educate patients about available healthcare 
coverage as well as legal recourse options in the event of malpractice. 
Combined with expanding the main State Department travel website 
to include the same information on each country, such public outreach 
would be extremely effective in channeling patient behavior.90 These 
organizations are valuable conduits of information because so many 
people reference their websites before travelling to identify needed 
travel vaccines, visa requirements, and travel advisories. Integrating 
information into these sites about healthcare quality, options for 
malpractice claims, and available self-insurance products will provide 
outbound patients with information about international healthcare that 
is relevant to making an informed decision about their choice in care. 
It would encourage patients to seek care in an environment that 
provides coverage and recourse at a level that satisfies patient 
expectations and with which they are comfortable. It will encourage 
better care and remedy and effectively channel patients into a higher 
quality care environment. 
 
 
 
                                                            
88 See COHEN, supra note 1, at 96–97. 
89 See e.g., U.S. Citizen Services: Lawyers and Doctors, EMBASSY OF THE U.S.: 
SAN JOSE, COSTA RICA, http://costarica.usembassy.gov/service/lawyers-and-
doctors2.html (last visited Feb. 3, 2015) (listing typical information found on the 
website or from the office of each American diplomatic mission). 
90 See COHEN, supra note 1, at 108–15. 
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B. Keeping Physicians Engaged 
The obverse party in the international healthcare relationship 
is the physician. For all of the reasons detailed above, physicians have 
powerful incentives to both offer patients remedy and mitigate the 
potential costs of those remedies to preserve the financial savings they 
offer. If physicians continue to present no remedy in the face of high 
profile adverse outcomes, they will forfeit their opportunity to attract 
patients. However, if transaction costs associated with remedies erode 
cost savings, physicians will once again forfeit their chances at 
winning over American patients. Finally, if the only option is to pay 
out-of-pocket for corrective care in the United States and be hauled 
before an American court, many physicians will walk away from the 
American market, focusing instead on patients from a less litigious 
society where big damage awards are less common.91 The treating 
countries share the same concerns as individual physicians; not 
because of the prospect for personal financial ruin, but for the 
possibility of massive losses to the national reputation affecting many 
economic sectors.92 The country’s worries aggregate those of all the 
individual physicians with added concern over harming the tourism, 
hospitality, and travel sectors of their economy.93 
The ISAPS Insurance regime protects these interests as well. 
Once again, the insurance attempts to use quality indicators to keep 
complication rates, and therefore premiums, low.94 The plan limits the 
physician’s exposure by allowing them to choose their indemnity to 
between 2,000 and 15,000 in either American Dollars, Euro, or 
Pounds.95 The operating physician pays a premium of six percent of 
the indemnity coverage.96 As a result, the patient receives coverage 
                                                            
91 Wiener, supra note 54. 
92 See Jonathan Head, The Dark Side of Cosmetic Surgery in Thailand, BBC 
NEWS (Feb. 12, 2015), http://www.bbc.com/news/business-31433890 (suggesting 
specific cases implicate the overall quality of Thai healthcare). 
93 See Kelley, supra note 9 (noting Singapore received 850,000 patients in 2012 
generating $3.5 billion in revenue); See also Connell, supra note 36, at 132-33 
(noting medical tourists spend two to three times more than standard tourists with a 
significant amount of spending outside of healthcare and creating many non-
healthcare jobs). 
94 See ISAPS, The Policy, supra note 72. 
95 Surgeon’s Guide, ISAPS INS., http://isapsinsurance.com/documents (last 
visited Feb. 25, 2015). 
96 Id. 
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for corrective procedures for up to two years following the original 
treatment.97 Especially important in the context of international 
healthcare, if the patient-physician relationship has broken down or it 
is not possible for the patient to return to the original physician, the 
insurance will cover the correction by a highly trained and qualified 
surgeon in the patient’s home country.98 
The resulting remedy helps bridge the gap between a 
potentially crippling financial award and leaving the patient out in the 
cold with no options. If a physician coverage regime were employed 
reasonably and in conjunction with patient purchased coverage, the 
adverse outcomes would be less acerbic except in the most extreme 
cases. Just like cases in domestic healthcare, any adverse outcome is 
sensitive but when patients have options, the situation is less likely to 
balloon into a damaging media firestorm that harms the physician’s 
and nation’s reputation. 
The premiums involved are modest but do consume some of 
the cost savings foreign providers tend to present, which can 
challenge the allure of international healthcare.99 As costs increase, 
patients may be more likely to bypass protections and go to another 
provider. Perhaps patients will be won over by more impressive 
marketing and patient testimonials, thinking the additional insurance 
unnecessary in a location that looks, but might not actually be, higher 
quality. Alternatively, some patients may simply opt to stay home.100  
It is difficult to strike a balance in the international healthcare 
market. Physicians must attract patients by demonstrating comparable 
quality to that available in the patient’s home country. They must also 
be careful not to over trivialize healthcare into a purely consumer 
endeavor so that patients believe they can go anywhere and be treated 
safely. And they must do so while offering sizeable cost savings. The 
phrase “but it was just a minor procedure” abounds. Patient and 
physician insurance policies offer a significant development capable 
                                                            
97 Id. 
98 Id. 
99 See Deloitte, Consumers in Search of Value, supra note 9, at 6 (identifying 
cost savings as a key driver in international healthcare). 
100 See Deloitte Center for Health Solutions, Medical Tourism: Update and 
Implications 1, 11 (2009) http://www.deloitte.com/assets/Dcom-
UnitedStates/Local%20assets/documents/us_chs_medicaltourism_111209_web.pdf 
(indicating a fifty percent cost saving is a critical threshold to get patients to travel 
outside their community for care). 
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of protecting those who seek care abroad before costs are incurred and 
in a way that limits the exposure of both parties to financial distress.  
VII. CONCLUSION 
The people who seek foreign care are not merely passengers, 
travelers, consumers, or customers. They are patients, and it is the 
responsibility of the legal profession to keep that distinction in focus, 
while helping foster the appropriate protective institutions. The large 
number of patients traveling for care, whom have not been 
incentivized to do so by employers or insurers, are utterly exposed at 
present. They have no opportunity to recover for malpractice. As a 
result, the patients and the American healthcare system risk absorbing 
the cost of complications on a personal and national level. In the 
absence of a universally recognized international court system to 
enforce malpractice judgments, which seems unlikely, a network of 
bi-lateral institutions is needed. 
The Romulus and Remus of international medical malpractice 
have been born in the form of Costa Rica’s bi-lateral alternative 
dispute resolution forum and ISAPS’ procedure-specific insurance 
regime. These are not mature and finished solutions. They are the 
infant versions of what will eventually emerge to offer patients 
malpractice protection. These schemes must be studied, emulated, and 
improved upon to create an international healthcare system that 
approximates the protections American patients enjoy at home 
without driving costs beyond reach.  
The solutions discussed in this Article pose the greatest 
benefit to the independent patient seeking outpatient care in an 
unaffiliated clinic. Such patients act without the prodding of an 
employer or insurer, and without the help of a facilitator. Therefore, 
no established theories of liability exist to give these patients recourse 
against tortfeasors in American courts. However, even if American 
case law develops to hold domestic agents liable for foreign 
malpractice against insured patients or those who have been referred 
to international care by their employer, the regimes discussed herein 
would still add an additional layer of patient consumer protection that 
is currently unavailable.  
 
